ACXP
Acurx Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $6.50M | Price | $5.02 |
| Volume | 122.32K | Change | -1.57% |
| P/E Ratio | -0.5 | Open | $5.00 |
| Revenue | -- | Prev Close | $5.10 |
| Net Income | $-14.1M | 52W Range | $3.80 - $38.00 |
| Div Yield | N/A | Target | $27.00 |
| Overall | 42 | Value | 60 |
| Quality | -- | Technical | 25 |
No chart data available
Stock Overview
Updated DailyAcurx Pharmaceuticals Inc. (ACXP) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $5.02 with a market capitalization of $6.50 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ACXP with a volume of 122K shares. The stock opened down 1.96% from yesterday's close of $5.10. Current analyst estimates project earnings of $-7.14 per share for this year, with next year targeting $-6.03.
ACXP demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ACXP include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 437.8%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:19 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACXP | $5.02 | -1.6% | 122.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Acurx Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW